drugset / Trial / NCT00003041
Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
Phase 2
Completed
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating women who have refractory metastatic breast cancer.
Timeline
- Start
- 1997-07
- Primary completion
- —
- Completion
- 2002-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pyrazoloacridine | Small molecule | — | Intravenous |